Freenome wins $300m funding for multiomics blood testing platform
The funding will help the company to accelerate the commercialisation of its blood test for colorectal cancer (CRC)…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
08 Dec 21
The funding will help the company to accelerate the commercialisation of its blood test for colorectal cancer (CRC)…
08 Dec 21
IOPerfect combines AI-based visual analysis in a VR-like headset to enable tele-diagnosis and remote monitoring of glaucoma
08 Dec 21
The trial will evaluate Tria biopolymer aortic valve in surgically treating the patients with aortic valve disease
08 Dec 21
HealthPulse@home provides a faster, less expensive, hassle-free option for laboratories looking to offer COVID-19 specimen collection kits in…
08 Dec 21
Provista Diagnostics is Todos Medical’s wholly-owned CLIA/CAP certified lab that offers comprehensive, fast, automated COVID-19 testing solutions that…
08 Dec 21
Flagship has unveiled the new company with $50m committed capital, after three years of research and development
08 Dec 21
StrandDx-ASD is developed based on Linus Biotechnology's proprietary exposome and biological response sequencing platform
07 Dec 21
According to the company's analysis, its Covid-19 test portfolio has detection coverage for all variants of interest and…
07 Dec 21
Cernostics' TissueCypher platform leverages an approach that consolidates important elements of AI to deliver the spatialomics revolution to…
07 Dec 21
The contract with Vizient — whose members represent more than half of the hospitals and health systems in…